Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices 5237 

Proposed Project 

Preventive Health and Health Services 

Block Grant (OMB Control No. 0920– 

0106, Exp. 2/29/2024)—Revision— 

National Center for State, Tribal, Local 

and Territorial Public Health 

Infrastructure and Workforce 

(NCSTLTPHIW), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The CDC’s National Center for State, 

Tribal, Local and Territorial Public 

Health Infrastructure and Workforce 

(NCSTLTPHIW) plays a vital role in 

helping health agencies work to 

enhance their capacity and improve 

their performance to strengthen the 

public health system on all levels. 

NCSTLTPHIW is CDC’s primary 

connection to health officials and 

leaders of State, Tribal, local, and 

Territorial public health agencies, as 

well as other government leaders who 

work with health departments. 

NCSTLTPHIW administers the 

Preventive Health and Health Services 

Block Grant (PHHSBG) for health 

promotion and disease prevention 

programs. Sixty-one (61) recipients (50 

states, the District of Columbia, two 

American Indian Tribes, five U.S. 

territories, and three freely associated 

states) receive block grant funds to 

address locally-defined public health 

needs in innovative ways. The PHHSBG 

allows awardees to prioritize the use of 

funds to fill funding gaps in programs 

that deal with leading causes of death 

and disability, as well as the ability to 

respond rapidly to emerging health 

issues, including outbreaks of foodborne infections and water-borne 

diseases. 

As specified in the authorizing 

legislation for the PHHSBG, CDC 

collects information from recipients to 

monitor their objectives and activities. 

Since 2021, this information has been 

reported through a web-based electronic 

system, the Block Grant Information 

System (BGIS). Each recipient is 

required to submit a work plan with its 

selected health outcome objectives, as 

well as descriptions of the health 

problems, identified target populations 

(including portions of those populations 

disproportionately affected by the 

health problems), and activities to be 

addressed in the planned work. 

In this Revision, CDC requests OMB 

approval to subdivide the previously 

approved annual Workplan (12 hours) 

into two sections: the ‘‘Workplan Start 

and Advisory Committee Questions 

Worksheet’’ (two hours) and the 

‘‘Workplan Program Questions 

Worksheet’’ (10 hours). There are no 

changes to the previously approved 

questions or the net annualized burden 

estimate for the Workplan (732 hours). 

However, questions have been 

regrouped to improve logical flow, and 

selected instructions to respondents 

have been revised for clarity and ease of 

use. The Annual Progress Report will be 

continued without changes in total 

burden hours (671 annualized burden 

hours), though the burden table is 

revised to describe how program 

collects two different sets of questions 

within the Annual Progress Report 

(Interim progress questions (seven 

hours) and Final progress questions 

(four hours). These revisions to the 

burden table enable program to better 

monitor and provide technical 

assistance to respondents. The Recipient 

Information Collection will be deleted 

from the burden table (¥122 annualized 

burden hours). The BGIS will retain this 

information, however, the one-time 

burden of entering the Recipient 

Information was accounted for in the 

previous approval period. 

CDC will continue to use the PHHSBG 

information collection to identify 

activities and personnel supported with 

Block Grant funding, monitor 

expenditure of funds and recipients’ 

progress toward their objectives, 

conduct compliance reviews of Block 

Grant recipients, and promote the use of 

evidence-based guidelines and 

interventions. OMB approval is 

requested for three years. All 

information is submitted annually 

through the electronic BGIS. The total 

annualized estimated burden is 1,403 

hours. There are no costs to respondents 

other than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

PHHS Block Grant Coordinator ...................... Workplan start and advisory committee 

questions worksheet.

61 1 2 

PHHS Block Grant Coordinator ...................... Workplan program questions worksheet ....... 61 1 10 

PHHS Block Grant Coordinator ...................... Annual Progress Report template (subset of 

Interim Progress questions).

61 1 7 

PHHS Block Grant Coordinator ...................... Annual Progress Report template (subset of 

Final Progress questions).

61 1 4 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–01549 Filed 1–25–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–24CB; Docket No. CDC–2024– 

0004] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Evaluation of an 

Online Prostate Cancer Decision Aid. 

This three-arm, randomized controlled 


lotter on DSK11XQN23PROD with NOTICES1
5238 Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices 

trial (RCT) includes eight forms of data 

collection including surveys and 

interviews and will evaluate the impact 

of a virtual human decision aid to help 

improve the quality of prostate cancer 

screening and treatment decisions. 

DATES: CDC must receive written 

comments on or before March 26, 2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0004 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Evaluation of an Online Prostate 

Cancer Decision Aid—New—National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC), Division of Cancer 

Prevention and Control (DCPC) is 

requesting a new, three-year OMB 

approval to conduct a three-arm, 

randomized controlled trial (RCT) to 

evaluate the impact of a virtual human 

decision aid to help improve the quality 

of prostate cancer screening and 

treatment decisions. 

Talk to Nathan About Prostate Cancer 

Screening (hereafter referred to as 

Nathan) is DCPC’s online, interactive, 

human simulation decision aid 

designed to help men learn and make 

informed decisions about prostate 

cancer screening. A small, preliminary 

evaluation of Nathan showed promise in 

increasing men’s knowledge about 

prostate cancer and likelihood of 

engaging in shared decision-making 

about prostate cancer screening with 

their health care providers. At this time, 

a larger, more systematic evaluation can 

help to understand whether Nathan is 

effective in areas such as improving 

knowledge, overcoming health literacy 

barriers, and resolving decisional 

conflict, especially among priority 

populations who are most likely to be 

affected by prostate cancer and least 

likely to be screened. Further, as some 

experts consider the digital divide to be 

the newest social determinant of health, 

it is important to explore how, where, 

and for which populations there may be 

disparities in accessing and using 

Nathan. 

Broadly, the purpose of this 

information collection is to: (1) assess 

whether Nathan is more effective at 

helping men make decisions about 

prostate cancer screening than an 

established decision aid or standard 

educational materials; (2) determine if 

changes or improvements to Nathan are 

warranted; and (3) identify ways to 

incorporate Nathan into primary care. 

We will select four primary care clinics 

to participate in this study. The RCT 

includes a three-group parallel design 

with one treatment arm and two control 

arms to test the effectiveness of Nathan 

for men aged 55–69. We will recruit 900 

men aged 55–69 who have an upcoming 

general health exam at one of the four 

primary care clinics and randomize 

them to one of three arms: (1) Nathan 

(Intervention = 300 men); (2) the 

Massachusetts Department of Public 

Health’s (MDPH’s) Patient Decision Aid, 

Get the Latest Facts about Screening for 

Prostate Cancer (Control 1 = 300 men); 

and (3) standard educational materials 

from the National Cancer Institute (NCI), 

Prostate Cancer Screening (PDQ®)— 

Patient Version (Control 2 = 300 men). 

Eight information collection forms 

will be implemented to answer our 

evaluation questions. These include a 

provider survey; a patient eligibility 

screener; patient pre-exposure, postexposure, and post-clinic visit surveys; 

a patient usability survey; patient user 

experience interviews; and clinic 

coordinator interviews. Each instrument 

will be administered once per 

respondent throughout the course of the 

study. The provider survey and clinic 

coordinator interviews will be 

conducted in English only. All other 

information collections will be 

conducted in English or Spanish. The 

total response burden is estimated to be 

1,129 hours. There are no costs to 

respondents other than their time to 

participate in data collection activities. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices 5239 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Primary care providers ...................... Provider survey ................................ 40 1 10/60 7 

Men ages 55–69 ............................... Patient eligibility screener ................ 900 1 8/60 120 

Men ages 55–69 ............................... Pre-exposure survey ........................ 900 1 20/60 300 

Men ages 55–69 ............................... Post-exposure survey ...................... 900 1 20/60 300 

Men ages 55–69 ............................... Post-clinic survey ............................. 300 1 18/60 90 

Men ages 55–69 ............................... Usability survey ................................ 30 1 20/60 10 

Men ages 55–69 ............................... User experience interview ................ 900 1 20/60 300 

Clinic coordinators ............................ Clinic coordinator interview .............. 4 1 30/60 2 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,129 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–01550 Filed 1–25–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10887] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

March 26, 2024. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: 

CMS, Office of Strategic Operations and 

Regulatory Affairs, Division of 

Regulations Development, Attention: 

Document Identifier/OMB Control 

Number: lll, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10887 The Medicare 

Advantage and Prescription Drug 

Programs: Part C and Part D Medicare 

Advantage Prescription Drug (MARx) 

System Updates for the Medicare 

Prescription Payment Plan Program 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: New collection (Request for a 

new OMB control number); Title of 

Information Collection: The Medicare 

Advantage and Prescription Drug 

Programs: Part C and Part D Medicare 

Advantage Prescription Drug (MARx) 

System Updates for the Medicare 

Prescription Payment Plan Program; 

Use: The IRA amended the Act by 

adding section 1860D–2(b)(2)(E) which, 

beginning January 1, 2025, establishes 

the Medicare Prescription Payment Plan 

program (hereinafter referred to as the 

‘‘program’’). Under this program, MA 

Organizations offering Part D coverage 

and Part D sponsors (collectively ‘‘Part 

D plans’’ or ‘‘Plans’’) are required to 

offer enrollees the option to pay their 

Part D cost sharing in monthly amounts 

spread out over the plan year based on 

the formulae described in section 

1860D–2(b)(2)(E)(iv) of the Act. 


lotter on DSK11XQN23PROD with NOTICES1